MakeMyTrip raises billions in fresh equity and notes, reviving dilution debate
What's the deal? MakeMyTrip has completed a large equity offering alongside 0.00% convertible senior notes, raising billions in fresh capital in July 2026. The Nasdaq-listed Indian travel company said the raise boosts its cash reserves but also opens the door to future share dilution for existing shareholders.
Why now? The capital arrives after a sharp rebound: shares returned 30.07% over 30 days and 49.86% over 90 days. Yet the stock remains down 29.97% year-to-date, with a one-year total shareholder return of -40.04% — a picture of momentum rebuilding after a weak year.
What's the endgame? MakeMyTrip is investing in product innovation, particularly AI-powered personalisation and user experience. Analysts argue this positions it for higher conversion rates, better retention, and expanding net margins through improved operating leverage.
What could go wrong? Dilution risk tops the bear case. The company also faces high customer acquisition costs and concentrated exposure to India, factors that could unsettle both margin and growth assumptions.
Valuation is the sharper flashpoint. MakeMyTrip's most-followed analyst narrative pegs fair value at $70.73, versus a last close of $57.35 — implying the stock is 18.9% undervalued. The market's pricing tells another story: a price-to-earnings ratio of 105x sits far above the US hospitality average of 23.8x and a fair ratio of 56.6x.
The signal: A quick re-raise after a rally is a classic move to lock in a stronger balance sheet while sentiment is warm. But with the P/E multiple stretched well beyond peers, the raise reopens a core question for investors — whether the market is paying for growth that is already priced in.
Read more: simplywall.st
Image credit: World Travel & Tourism Council
